Gabapentin will become a Schedule 5 controlled substance in Kentucky effective July 1, 2017.

The Cabinet’s Drug Enforcement and Professional Practices Branch prepared the attached fact sheet to provide general information to practitioners and pharmacies regarding the change.
This fact sheet is posted on the KASPER public web page at www.chfs.ky.gov/KASPER